Investors Overview

Webcast ImageWebcast
Bacterin International Holdings Inc Management Update Call (Replay)
07/28/15 at 8:00 a.m. ET
Bacterin International Holdings Inc Management Update Call
Tuesday, July 28, 2015 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (OTCQX: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in...
More

Stock Quote
BONE (Common Stock)
ExchangeOTC BB (US Dollar)
Price$3.52
Change (%) Stock is Down 0.18 (4.86%)
Volume8,622
Data as of 07/31/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
07/31/15Bacterin International Holdings Closes Offering of $65 Million of 6.00% Convertible Senior Notes
BELGRADE, Mont., July 31, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has announced the closing of its previously announced offering of $65 million aggregate principal amount of convertible senior unsecured notes due 2021 (the "Notes"). The Notes were offered and sold to "qualified institutional buyers" (as defined in Rule 144A under the Securities Act of 1933, as amended). Bacterin has granted the... 
Printer Friendly Version
07/31/15Bacterin Closes Purchase of the Outstanding Common Stock of X-spine Systems, Inc.
Combines Bacterin's Strength in Orthobiologics With X-spine's Expertise in Hardware Offering Complementary Product Lines Focused on Orthopedic and Spine Surgical Procedures BELGRADE, Mont., July 31, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, announced today that it has closed its purchase of the outstanding shares of privately held X-spine Systems, Inc., a global medical device manufacturer of le... 
Printer Friendly Version
07/27/15Bacterin International Holdings Prices $65 Million of 6.00% Convertible Senior Notes
BELGRADE, Mont., July 27, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, has announced the pricing of $65 million aggregate principal amount of convertible senior unsecured notes due 2021 (the "Notes"). The Notes are being offered and sold to "qualified institutional buyers" (as defined in Rule 144A under the Securities Act of 1933, as amended). Bacterin has granted the investment banking firm serving... 
Printer Friendly Version
07/27/15Bacterin to Purchase the Outstanding Common Stock of X-spine Systems, Inc., Creating Xtant Medical
Combines Bacterin's strength in orthobiologics with X-spine's expertise in hardware offering complementary product lines focused on orthopedic and spine surgical procedures. Pro forma revenue and EBITDA for the combined company for the 12 months ended December 31, 2014 was approximately $77.5 million and $3.9 million, respectively. Strategic combination to offer complementary product lines to more comprehensively serve customers for a wide range of orthopedic and spine surgical pro... 
Printer Friendly Version
More

Upcoming Events
There are currently no events scheduled.
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.